Annual Current Assets
$464.67 M
+$82.53 M+21.60%
December 31, 2023
Summary
- As of February 7, 2025, AMLX annual total current assets is $464.67 million, with the most recent change of +$82.53 million (+21.60%) on December 31, 2023.
- During the last 3 years, AMLX annual current assets has risen by +$451.03 million (+3306.89%).
- AMLX annual current assets is now at all-time high.
Performance
AMLX Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$245.26 M
-$81.46 M-24.93%
September 30, 2024
Summary
- As of February 7, 2025, AMLX quarterly total current assets is $245.26 million, with the most recent change of -$81.46 million (-24.93%) on September 30, 2024.
- Over the past year, AMLX quarterly current assets has dropped by -$188.85 million (-43.50%).
- AMLX quarterly current assets is now -47.22% below its all-time high of $464.67 million, reached on December 31, 2023.
Performance
AMLX Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
AMLX Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +21.6% | -43.5% |
| 3 y3 years | +3306.9% | -43.5% |
| 5 y5 years | +10000.0% | -43.5% |
AMLX Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +342.8% | -47.2% | +133.7% |
| 5 y | 5-year | at high | >+9999.0% | -47.2% | +1698.3% |
| alltime | all time | at high | >+9999.0% | -47.2% | +1698.3% |
Amylyx Pharmaceuticals Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $245.26 M(-24.9%) |
| Jun 2024 | - | $326.72 M(-20.4%) |
| Mar 2024 | - | $410.53 M(-11.6%) |
| Dec 2023 | $52.79 M(+466.4%) | $464.67 M(+7.0%) |
| Sep 2023 | - | $434.11 M(+1.6%) |
| Jun 2023 | - | $427.39 M(+9.9%) |
| Mar 2023 | - | $389.05 M(+1.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $9.32 M(+1305.7%) | $382.13 M(+121.9%) |
| Sep 2022 | - | $172.20 M(-20.3%) |
| Jun 2022 | - | $216.14 M(-18.6%) |
| Mar 2022 | - | $265.49 M(+153.0%) |
| Dec 2021 | $663.00 K(+42.6%) | $104.95 M(-19.2%) |
| Sep 2021 | - | $129.94 M(+852.7%) |
| Dec 2020 | $465.00 K(+2483.3%) | $13.64 M |
| Dec 2019 | $18.00 K | - |
FAQ
- What is Amylyx Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals annual current assets year-on-year change?
- What is Amylyx Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals quarterly current assets year-on-year change?
What is Amylyx Pharmaceuticals annual total current assets?
The current annual current assets of AMLX is $464.67 M
What is the all time high annual current assets for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high annual total current assets is $464.67 M
What is Amylyx Pharmaceuticals annual current assets year-on-year change?
Over the past year, AMLX annual total current assets has changed by +$82.53 M (+21.60%)
What is Amylyx Pharmaceuticals quarterly total current assets?
The current quarterly current assets of AMLX is $245.26 M
What is the all time high quarterly current assets for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high quarterly total current assets is $464.67 M
What is Amylyx Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, AMLX quarterly total current assets has changed by -$188.85 M (-43.50%)